Pharma: Bafin checks Dermapharm's balance sheet for irregularities - shares fall sharply
⚡ Quick Summary
The drugmaker is said to have violated accounting rules in its annual financial statements for 2025, regulators said.
📰 Related Articles
European Cup qualification: Controversial penalty sparks turmoil in Malta
Der Spiegel
Handelsblatt
Andy Burnham is the new Labor leader - and is set to become prime minister on Monday
Die Welt
Karol Nawrocki: Poland's President stops the introduction of registered civil partnerships
Die Zeit
Was violence called for?: “Die Anstalt” makers and Danger Dan attack ZDF for song ban
n-tv